You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. 3D Scaffold and Stem Cell Based Bioengineered Skin for Treatment of Cutaneous Vesicant Injury

    SBC: Nomadics, Inc.            Topic: CBD05117

    In this Phase II project Nomadics will novate our research to a spin-out company Nico Technologies. Nomadics will remain a subcontractor during this transition. The team proposes a new treatment for injuries from mustard gas based on biodegradable inverted colloidal crystal scaffolds impregnated with stem cells. Phase I results demonstrated excellent performance of these scaffolds for different ...

    SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense
  2. Chemical Warfare Agent (CWA) Lightweight Field-Portable (Hand-Held) Medical Diagnostic Tool

    SBC: RAPID PATHOGEN SCREENING, INC.            Topic: CBD06104

    The U.S. Army Medical Research Acquisition Activity at Fort Detrick, MD awarded an SBIR Phase I contract to Rapid Pathogen Screening, Inc. (RPS) in May 2006. The overall objective of this SBIR topic is to develop a lightweight field-portable (i.e., hand-held) device that fulfills a two-fold purpose as follows: (1) it will detect/identify Chemical Warfare Nerve Agents (CWNAs) of operational conce ...

    SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense
  3. Analysis Tools for Detection and Diagnosis of Biological Threats

    SBC: ALPHA-GAMMA TECHNOLOGIES, INC.            Topic: CBD04113

    DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...

    SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
  4. Hermetic Textile Closure Hardware System

    SBC: SIGMA K CORP            Topic: CBD04110

    Effective collective protection fabrics must have a reliable closure system. During our Phase I Work Plan, Sigma-K began developing a Hermetic Textile Closure Hardware (HATCH) system. The HATCH combines both a magnetic and geometric self locking mechanism that will provide a hermetic seal when closed. Our current Phase I successes include developing self closing samples that can provide a hermetic ...

    SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
  5. CW Indicating Chromophore for Decontamination Operations

    SBC: Nomadics, Inc.            Topic: CBD04103

    In Phase I, Nomadics demonstrated that a novel chemical weapon indicating chromophore (CWIC) developed by Professor Tim Swager at MIT will allow equipment to be quickly and easily examined to show any areas of contamination, making targeted decontamination manageable. When exposed to CW agent simulants, CWICs react to become fluorescent under UV stimulation. In the first phase, we implemented a s ...

    SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
  6. Model-Based Design of Test Systems for Chemical Protective Clothing

    SBC: CREARE LLC            Topic: CBD02202

    The current methodology for testing the penetration resistance of textile materials to various chemical agents has a number of drawbacks, including significant uncertainties in the resulting data, inefficiency and expense, risk to test personnel, and limited range of test conditions. The objective of the proposed work is to apply unique computer models for textiles with accompanying experimental ...

    SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
  7. Novel THz-frequency spectrometers by integrating widely-tunable monochromatic THz sources and detectors, or arrays of emitters and detectors, with pho

    SBC: ArkLight            Topic: CBD04104

    By continuing teaming up with one of the most reputable university teams in THz science and technology, ArkLight proposes to carry out the tasks set for a Phase-II program following our success in Phase I. We are aimed at the further development of novel spectrometers to analyze chemicals in the vapor phase based on accurate measurements of the emission and absorption spectra due to the molecular ...

    SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
  8. AUTOMATIC EGG INJECTION MACHINE

    SBC: Embrex            Topic: N/A

    THE U.S. POULTRY INDUSTRY ADMINISTERS ABOUT 21 BILLION DOSE UNITS OF VACCINES YEARLY. THESE VACCINATIONS ARE GIVEN TO TO DAY-OLD BIRDS FOR SEVERAL VIRAL AND BACTERIAL DISEASES, AND SUBSEQUENT VACCINATIONS TO GROWING AND ADULT CHICKENS ANAND TURKEYS. ADDITIONALLY, 170 MILLION TURKEY EMBRYOS R RECEIVE ANTIBIOTIC TREATMENT. THE WORLDWIDE POULTRY DRUG VACCINE MARKET REPRESENTS OVER $500 MILLION PR YEA ...

    SBIR Phase II 1987 Department of Agriculture
  9. Enhancement of Early Development in Turkeys by in Ovo Feeding

    SBC: Embrex            Topic: N/A

    Approximately 5% of hatchlings do not survive the critical post-hatch period because of limited body reserves. Many survivors exhibit stunted growth, leg problems, inefficient feed utilization, reduced disease resistance, or poor meat yield. This poult quality problem has been calculated to be worth approximately $71 million and $142 million annually to the US and global turkey industry respective ...

    SBIR Phase II 2005 Department of Agriculture
  10. Developing Medicinally Used Echinacea Cultivars by Intra- and Interspecific Hybridization- Phase II

    SBC: Gaia Herbs, Inc.            Topic: N/A

    Cultivation of Echinacea has gained worldwide interest in recent years due to its non-specific immunomodulatory activity in humans. However, Echinacea species have not been genetically improved for medicinal use. This project is to develop genetically improved Echinacea cultivars for medicinal use. The new cultivars will produce higher yield of biomass and bioactive phytochemicals than the types c ...

    SBIR Phase II 2005 Department of Agriculture
US Flag An Official Website of the United States Government